论文部分内容阅读
目的探讨阿奇霉素治疗支原体肺炎临床评价。方法选取我院2010年1月至2015年8月收治的120例支原体肺炎患儿为研究对象,并随机分为对照组和观察组。其中,对照组患儿60例采用常规红霉素治疗,观察组患儿60例采用阿奇霉素进行治疗,最后再对比两组治疗效果。结果经过治疗,观察组患儿的退热时间、止咳时间和啰音消失时间,以及不良反应等,均优于对照组,P<0.05。且对比两组总有效率,有统计学意义,P<0.05。结论对我院120例支原体肺炎患儿分别采用红霉素和阿奇霉素治疗,可见阿奇霉素在治疗小儿支原体肺炎中更为安全、有效,具有推广意义。
Objective To investigate the clinical evaluation of azithromycin in the treatment of mycoplasma pneumonia. Methods 120 children with mycoplasma pneumonia admitted in our hospital from January 2010 to August 2015 were selected as the research object and randomly divided into control group and observation group. Among them, the control group of 60 children treated with conventional erythromycin, 60 cases of observation group treated with azithromycin, and finally compared the two groups of treatment. Results After treatment, the observation group patients with antipyretic time, cough and rales disappear time, and adverse reactions were better than the control group, P <0.05. And compared the two groups total effective rate, with statistical significance, P <0.05. Conclusion 120 cases of mycoplasma pneumonia in children were treated with erythromycin and azithromycin, azithromycin can be seen in the treatment of children with mycoplasma pneumonia more secure and effective, with the promotion of significance.